The Smart Ring That Tracks Everything Just Filed for a $2.2 Billion IPO — And Wearables Will Never Be the Same

I've been wearing an Oura Ring for two years, and today the company just made it official: they're going public. Oura Inc. filed for an IPO on September 21, 2026, looking to raise up to $2.2 billion on the Nasdaq under the ticker symbol OURA. If you've ever seen one of those sleek rings on someone's finger and wondered what it does, that company is now about to become one of the most talked-about IPOs of the year.

What Is Oura and Why Does It Matter?

Oura makes a smart ring — a small, titanium ring packed with sensors that tracks your sleep, heart rate variability, body temperature, activity, and overall readiness score. Unlike a smartwatch, it's discreet enough that most people don't even notice you're wearing a health tracker. And the data it generates is genuinely impressive — I've used it to figure out when I'm getting sick before I actually feel sick, catch sleep debt before it tanks my performance, and optimize my recovery after hard workouts.

The company has sold 4.1 million Oura Rings in the nine months ending June 30, 2026 — up from just 1.8 million in the same period the previous year. That's more than double the sales in a single year. People are clearly hungry for this kind of health data.

The IPO Numbers

Here's what the filing reveals: Oura plans to issue 50 million shares priced between $40 and $44 each, potentially valuing the company at approximately $14.1 billion at listing. Of those 50 million shares, only 13.5 million are new shares from the company itself — the remaining 36.5 million are existing shareholders cashing out.

The company reported revenue of $1.21 billion in the nine months ending June 30, 2026, but also posted a significant net loss of $924.3 million. Hardware made up most of the revenue at $974 million, while membership revenue (monthly subscription fees) more than doubled to $240.5 million — a promising sign for recurring revenue growth.

Eli Lilly has expressed interest in purchasing up to $100 million worth of shares, and Dragoneer plans to buy up to $300 million. Goldman Sachs, Morgan Stanley, and J.P. Morgan are leading the offering.

Why This IPO Is Bigger Than Just a Ring Company

The Oura IPO signals something important about where consumer health technology is heading. We're moving from reactive healthcare — where you see a doctor after you're sick — to proactive, continuous health monitoring that gives you real-time data about your body every single day.

The partnership interest from Eli Lilly is particularly telling. Pharmaceutical companies are increasingly interested in wearable health data as a tool for drug trials, patient monitoring, and precision medicine. An Oura Ring on a trial participant's finger can collect data that would previously have required lab visits — that's a massive opportunity.

The Concerns I Have

I want to be honest: there are real risks here. The company is still losing significant money, and the IPO structure has most of the proceeds going to existing shareholders rather than the company itself. That's not a great sign for a company that clearly needs to keep investing in R&D and marketing to grow.

The wearables market is also getting more competitive by the day. Apple Watch keeps adding health features, Samsung has its Galaxy Ring, and a dozen other players are entering the space. Oura has a lead right now, but staying ahead requires constant innovation.

My Take as a Daily Oura User

I believe in the product deeply — my Oura Ring has genuinely changed how I think about sleep and recovery. But believing in the product and believing in the stock are two different things. The $14.1 billion valuation is aggressive for a company still posting large losses, even if the growth trajectory is strong.

What I'm watching: how quickly membership revenue grows as a share of total revenue (recurring software revenue is valued much higher than hardware), whether the Eli Lilly partnership leads to real pharmaceutical partnerships, and whether Apple decides to go after this market more aggressively with a ring of their own.

The Oura IPO is a landmark moment for digital health wearables. Win or lose on the stock, the product category it represents is here to stay.

What's your experience? Drop a comment below! 👇
Do you use an Oura Ring or any other health wearable? Are you excited about this IPO? Let me know your thoughts!